Unlike pentostatin, another ADA inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) can induce the apoptosis of malignant pleural mesothelioma (MPM), which is an aggressive tumor that does not have effective therapy. Here, ADA is linked to neoplasm.